203 related articles for article (PubMed ID: 23702679)
1. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening.
Tao S; Brenner H
Eur J Cancer Prev; 2013 Jul; 22(4):305-10. PubMed ID: 23702679
[TBL] [Abstract][Full Text] [Related]
2. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
[TBL] [Abstract][Full Text] [Related]
4. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
5. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
[TBL] [Abstract][Full Text] [Related]
6. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in performance of fecal occult blood testing.
Brenner H; Haug U; Hundt S
Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
9. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of a new immunochemical fecal occult blood test in Korean patients referred for colonoscopy.
Woo HY; Mok RS; Park YN; Park DI; Sung IK; Sohn CI; Park H
Clin Biochem; 2005 Apr; 38(4):395-9. PubMed ID: 15766742
[TBL] [Abstract][Full Text] [Related]
13. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
14. Low-dose aspirin use and performance of immunochemical fecal occult blood tests.
Brenner H; Tao S; Haug U
JAMA; 2010 Dec; 304(22):2513-20. PubMed ID: 21139112
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal cancer with immunochemical faecal occult blood tests.
Faivre J; Dancourt V; Lejeune C
Dig Liver Dis; 2012 Dec; 44(12):967-73. PubMed ID: 22898146
[TBL] [Abstract][Full Text] [Related]
16. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L
Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670
[TBL] [Abstract][Full Text] [Related]
17. Performance improvements of stool-based screening tests.
van Dam L; Kuipers EJ; van Leerdam ME
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.
Zorzi M; Fedato C; Grazzini G; Stocco FC; Banovich F; Bortoli A; Cazzola L; Montaguti A; Moretto T; Zappa M; Vettorazzi M
Gut; 2011 Jul; 60(7):944-9. PubMed ID: 21193461
[TBL] [Abstract][Full Text] [Related]
19. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.
Rozen P; Comaneshter D; Levi Z; Hazazi R; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Cancer; 2010 May; 116(9):2115-25. PubMed ID: 20186820
[TBL] [Abstract][Full Text] [Related]
20. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]